These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 20957395)

  • 21. AGEs, RAGE, and diabetic retinopathy.
    Zong H; Ward M; Stitt AW
    Curr Diab Rep; 2011 Aug; 11(4):244-52. PubMed ID: 21590515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products.
    Maeda S; Matsui T; Ojima A; Takeuchi M; Yamagishi S
    Nutr Res; 2014 Sep; 34(9):807-13. PubMed ID: 25241332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening system of blocking agents of the receptor for advanced glycation endproducts in cells using fluorescence.
    Jung DH; Kim YS; Kim JS
    Biol Pharm Bull; 2012; 35(10):1826-30. PubMed ID: 23037172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
    Basta G; Lazzerini G; Massaro M; Simoncini T; Tanganelli P; Fu C; Kislinger T; Stern DM; Schmidt AM; De Caterina R
    Circulation; 2002 Feb; 105(7):816-22. PubMed ID: 11854121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
    Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
    Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel inhibitors of glycation and AGE formation.
    Rahbar S
    Cell Biochem Biophys; 2007; 48(2-3):147-57. PubMed ID: 17709884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability.
    Zhou X; Weng J; Xu J; Xu Q; Wang W; Zhang W; Huang Q; Guo X
    Cell Physiol Biochem; 2018; 45(4):1717-1730. PubMed ID: 29490301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE)--an introduction.
    Thornalley PJ
    Mol Nutr Food Res; 2007 Sep; 51(9):1107-10. PubMed ID: 17854008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury.
    Zhang H; Wang Y; Yan S; Du F; Wu L; Yan S; Yan SS
    Cell Death Dis; 2014 Jun; 5(6):e1288. PubMed ID: 24922072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular disease: what's all the AGE/RAGE about?
    Barlovic DP; Thomas MC; Jandeleit-Dahm K
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):7-15. PubMed ID: 20041839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RAGE in diabetic nephropathy.
    Yamamoto H; Watanabe T; Yamamoto Y; Yonekura H; Munesue S; Harashima A; Ooe K; Hossain S; Saito H; Murakami N
    Curr Mol Med; 2007 Dec; 7(8):752-7. PubMed ID: 18331233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.
    Ramasamy R; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2011 Dec; 1243():88-102. PubMed ID: 22211895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).
    Baba SP; Hellmann J; Srivastava S; Bhatnagar A
    Chem Biol Interact; 2011 May; 191(1-3):357-63. PubMed ID: 21276777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.
    Hudson BI; Bucciarelli LG; Wendt T; Sakaguchi T; Lalla E; Qu W; Lu Y; Lee L; Stern DM; Naka Y; Ramasamy R; Yan SD; Yan SF; D'Agati V; Schmidt AM
    Arch Biochem Biophys; 2003 Nov; 419(1):80-8. PubMed ID: 14568011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unlocking the biology of RAGE in diabetic microvascular complications.
    Manigrasso MB; Juranek J; Ramasamy R; Schmidt AM
    Trends Endocrinol Metab; 2014 Jan; 25(1):15-22. PubMed ID: 24011512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications.
    Yamagishi S; Nakamura K; Matsui T; Ueda S; Fukami K; Okuda S
    Expert Opin Investig Drugs; 2008 Jul; 17(7):983-96. PubMed ID: 18549336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biology of the receptor for advanced glycation end products and its ligands.
    Schmidt AM; Yan SD; Yan SF; Stern DM
    Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications.
    Yan SF; Barile GR; D'Agati V; Du Yan S; Ramasamy R; Schmidt AM
    Curr Diab Rep; 2007 Apr; 7(2):146-53. PubMed ID: 17425919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress.
    Chen J; Song M; Yu S; Gao P; Yu Y; Wang H; Huang L
    Mol Cell Biochem; 2010 Feb; 335(1-2):137-46. PubMed ID: 19756958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1.
    Rai V; Maldonado AY; Burz DS; Reverdatto S; Yan SF; Schmidt AM; Shekhtman A
    J Biol Chem; 2012 Feb; 287(7):5133-44. PubMed ID: 22194616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.